STUDY OF DEMOGRAPHIC ASPECTS, CLINICAL CHARACTERISTICS AND THERAPEUTIC APPROACHES IN PSORIATIC ARTHRITIS PATIENTS | ||
| ALEXMED ePosters | ||
| Article 1, Volume 6, Issue 4, September 2024, Pages 69-70 | ||
| Document Type: Preliminary preprint short reports of original research | ||
| DOI: 10.21608/alexpo.2024.339110.2014 | ||
| Authors | ||
| Ibtessam Mohamed Abdelhamid1; Eiman Abdelmonem Soliman2; Abeer Ali Abdelati3; Amira Abulfotooh Eid4; Asmaa Mohamed Mohamed Sharaf* 5 | ||
| 1Professor of Internal Medicine, Faculty of Medicine, University of Alexandria. | ||
| 2Internal Medicine Department, Faculty of Medicine, Alexandria University | ||
| 3Assistant professor of Internal Medicine, Faculty of Medicine, University of Alexandria | ||
| 4Professor of Dermatology, Venerology and Andrology, Faculty of Medicine Alexandria University | ||
| 5Department of Internal Medicine, Alexandria Faculty of Medicine | ||
| Abstract | ||
| INTRODUCTION Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy associated with psoriasis. It was first described as a variant of rheumatoid arthritis (RA). However, PsA is considered a unique arthropathy with distinct clinical and radiological features. Diagnosis is most commonly made by identifying inflammatory musculoskeletal features in the joints, entheses or the spine in the presence of skin and/or nail psoriasis. PsA is associated with extra-articular manifestations including uveitis and inflammatory bowel disease. PsA is also associated with several chronic conditions, which may affect lifespan and quality of life (QoL). Obesity is particularly common in patients with PsA, and is significantly more prevalent than in patients with psoriasis or rheumatoid arthritis and the general population. In addition, PsA is associated with an increased prevalence of cardiovascular risk factors such as hypertension, hyperlipidemia, type 2 diabetes mellitus, and the combination of these (the metabolic syndrome). In addition, depression and anxiety are common in patients with PsA which have a substantial impact on treatment outcomes and, therefore, these comorbidities should be identified and managed so as to improve outcomes. | ||
| Keywords | ||
| PSORIATIC; ARTHRITIS; PATIENTS | ||
|
Supplementary Files
|
||
|
Statistics Article View: 8 |
||
